A group of Abbvie investors who say they and others like them collectively lost more than $100 million when the pharmaceutical giant used an after-hours press release to adjust a share price tender offer, has sued the company in a federal securities class action filed July 26 in Chicago.
An investor hit Tesla Inc. and its founder Elon Musk with a proposed securities fraud class action Friday in California federal court, claiming they tried to pump up stock prices by proclaiming plans to take the company private — without having the more than $71 billion privatizing would require.
A proposed class of AbbVie Inc. investors filed a stock drop suit against the pharmaceutical company in Illinois federal court Thursday, saying a corrective disclosure related to the company’s May stock buyback efforts led to a collective $100 million loss in value for the shareholders.
The trio who formed Gerchen Keller Capital (GKC) are moving on to a new venture just over a year after the $160 million sale of their litigation finance firm to Burford Capital Ltd. Adam Gerchen, Ashley Keller and Travis Lenkner have quietly launched Keller Lenkner, a plaintiff-side litigation firm in […]
As founders of one of the first and biggest litigation funding companies, the trio behind what was once Gerchen Keller Capital (GKC) became known for bringing financial innovation to a staid profession’s books. Now, they’re taking on the opioid crisis by putting a new twist on an en vogue type […]